Back to Journals » Open Access Journal of Clinical Trials » Volume 12

Study Protocol

MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease

       
Total article views   HTML views PDF downloads Totals
5,844 Dovepress* 5,844+ 1,255 7,099
Totals 5,844 1,255 7,099
*Since 7 January 2020
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 5 5

View citations on Google Scholar